Title : Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date.

Pub. Date : 2018

PMID : 29430197






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Results from studies combining buparlisib with different anticancer agents - namely, endocrine therapy, anti-HER2 therapy, and chemotherapy - have showed variable efficacy with consistent substantial toxicity. NVP-BKM120 erb-b2 receptor tyrosine kinase 2 Homo sapiens